the short answer
BPC-157 and TB-500 are often paired because they are studied for different parts of tissue repair: BPC-157 for repair and blood flow, TB-500 for cell migration and flexibility. The pairing is a hypothesis, not a proven clinical synergy in dogs.
The rationale
Repair is a multi-step process. One compound may support the scaffolding and blood supply; another may support the cells that migrate to the injury. That is the theory.
The evidence
Most of the data is preclinical. There is no controlled canine trial of the combination for arthritis or CCL tears. The stack is a research convention, not a proven protocol.
The honest position
We sell a research-use product, not a cure. The batch certificate and the published research are the proof we can offer; the medical decision belongs to your vet.
Questions owners ask
Do I need both compounds?
That is a vet question. The pen is formulated as a fixed combination; we do not sell single-compound pens.
Is the stack FDA-approved?
No. Neither compound is FDA-approved for dogs.
Is more better?
No. More is not better with research compounds. Follow the label and your vet.